Welcome to our dedicated page for Maximus SEC filings (Ticker: MMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Maximus runs large-scale health, welfare-to-work, and technology contracts for governments worldwide; that mix of service lines makes its SEC disclosures anything but straightforward. If you’ve ever searched “Where can I read the Maximus quarterly earnings report 10-Q filing?” or tried to decode revenue by segment in the annual 10-K, you know the challenge.
Stock Titan solves that complexity. Our AI engine scans every Maximus SEC filing the instant it hits EDGAR—whether it’s a Form 8-K announcing a new Medicaid contract or the proxy statement detailing executive compensation. You’ll see AI-powered summaries that turn legal prose into plain language, answering queries like “Maximus 8-K material events explained,” “understanding Maximus SEC documents with AI,” and delivering Maximus insider trading Form 4 transactions in real time.
- 10-K – Maximus annual report 10-K simplified with backlog and segment margin breakdowns.
- 10-Q – Maximus earnings report filing analysis that compares quarter-over-quarter trends.
- Form 4 – Maximus Form 4 insider transactions real-time for tracking executive stock activity.
- 8-K – Material contract wins and amendments distilled in minutes.
- DEF 14A – Maximus proxy statement executive compensation laid out clearly.
Whether you’re screening for cash-flow swings, monitoring “Maximus executive stock transactions Form 4,” or simply want “Maximus SEC filings explained simply,” our expert analysis, AI-generated highlights, and continuous updates deliver the insights you need—without wading through hundreds of pages.
Victory Capital Management, Inc. filed Amendment No. 3 to Schedule 13G reporting its beneficial ownership in Maximus, Inc. (MMS) common stock. The firm reported 17,364 shares, representing 0.03% of the class as of 09/30/2025.
Victory Capital reported sole voting power over 17,364 shares and sole dispositive power over 17,364 shares, with no shared voting or dispositive power. The filer is identified as an investment adviser under Rule 13d-1(b) and certified the securities were acquired and are held in the ordinary course of business without the purpose or effect of influencing control.
Theresa D. Golinvaux, listed as Principal Accounting Officer of MAXIMUS, Inc. (MMS), reported a transaction dated 09/30/2025 on a Form 4. The filing shows 1,206.759 shares of common stock were disposed of at a price of $91.37; the form explains these shares were surrendered to satisfy withholding tax related to the vesting of restricted stock units (RSUs). After the reported disposition, the reporting person beneficially owns 10,249.213 shares, which includes previously reported RSU awards totaling 5,628.387 RSUs and accrued dividend equivalents with varying distribution schedules. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 10/02/2025.
Michelle Link, Chief of Human Resources at MAXIMUS, Inc. (MMS), reported changes in beneficial ownership on a Form 4. On 09/30/2025 she surrendered 2,255.654 shares to satisfy withholding taxes from vested restricted stock units at a price of $91.37, leaving 15,118.065 shares reported immediately after that transaction. On 10/01/2025 she sold 1,610 shares at $90.86, reducing her reported beneficial ownership to 13,508.065 shares. The filing notes prior RSU awards representing 8,551.266 RSUs with dividend equivalents previously reported and that the sales on 10/01/2025 were executed under a 10b5-1 trading plan adopted on 12/06/2024. The Form is signed by an attorney-in-fact on behalf of the reporting person on 10/02/2025.
John T. Martinez, Chief Legal Officer of MAXIMUS, Inc. (MMS), reported a transaction dated 09/30/2025 disposing of 3,017.119 shares of common stock at $91.37 per share. The filing explains those shares were surrendered to satisfy withholding tax from the vesting of restricted stock units (RSUs). After the reported transaction the reporting person beneficially owns 15,199.192 shares, which includes 13,230.101 previously reported RSUs and accrued dividend equivalent rights with varying distribution schedules.
MAXIMUS, Inc. (MMS) filed a Form 144 notifying the proposed sale of 1,610 common shares held at Fidelity Brokerage Services with an aggregate market value of $146,284.60. The shares represent vested restricted stock acquired and paid as compensation on 09/30/2025. The filing lists approximately 56,349,629 shares outstanding for the issuer and an approximate sale date of 10/01/2025 on the NYSE. No securities were reported sold by the filer in the past three months. The notice includes the filer’s representation that they do not possess undisclosed material adverse information about the issuer.
MAXIMUS, Inc. announced an increase to its existing stock purchase program and said it intends to buy shares opportunistically in the open market, under 10b5-1 plans, or via privately negotiated transactions. The company specified the program has no set purchase amount or expiration date and may be extended, modified, suspended or discontinued at its discretion. A press release describing the increase is filed as Exhibit 99.1 to this Current Report. The filing includes standard forward-looking statements language and points investors to the company’s Annual Report for additional risk factors and disclosures.
Anne K. Altman, a director of MAXIMUS, Inc. (MMS), reported an acquisition on 08/31/2025 of dividend equivalent rights tied to previously awarded restricted stock units. The filing shows 10.491 dividend-equivalent shares were acquired at $0, and the reporting person now beneficially owns 32,055.435 shares (direct ownership). The filing explains these dividend equivalents vest proportionately with the underlying RSUs and are the economic equivalent of one share each. The form was signed by an attorney-in-fact on 09/03/2025.
Ilene Baylinson, General Manager - Health & Human at MAXIMUS, Inc. (MMS), received dividend equivalent rights on 08/31/2025 that converted to the economic equivalent of 129.906 shares of MAXIMUS common stock. These rights accrue alongside previously awarded restricted stock units and certain performance share units where performance criteria were met. Following the reported accrual, Ms. Baylinson beneficially owns 38,201.195 shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/03/2025. The filing discloses a routine equity accrual tied to awards rather than an open-market trade or option exercise.
Bruce Caswell, CEO & President and a director of MAXIMUS, Inc. (MMS), reported on Form 4 that on 08/31/2025 he acquired 807.268 shares of MAXIMUS common stock as dividend equivalent rights that accrued on previously awarded restricted stock units and certain performance share units. The transaction price is reported as $0. After the transaction, he beneficially owned 237,390.466 shares, held directly. The filing was signed by an attorney-in-fact on 09/03/2025. The form explains each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock.